6.95
0.07 (1.02%)
| 前收盘价格 | 6.88 |
| 收盘价格 | 6.92 |
| 成交量 | 661,480 |
| 平均成交量 (3个月) | 1,158,036 |
| 市值 | 647,835,328 |
| 预期市盈率 (P/E Forward) | 54.05 |
| 价格/销量 (P/S) | 0.570 |
| 股市价格/股市净资产 (P/B) | 1.28 |
| 52周波幅 | |
| 利润日期 | 3 Nov 2025 |
| 营业毛利率 | -12.20% |
| 营业利益率 (TTM) | -14.80% |
| 稀释每股收益 (EPS TTM) | -1.12 |
| 季度收入增长率 (YOY) | -3.10% |
| 总债务/股东权益 (D/E MRQ) | 22.36% |
| 流动比率 (MRQ) | 1.90 |
| 营业现金流 (OCF TTM) | -6.40 M |
| 杠杆自由现金流 (LFCF TTM) | 18.68 M |
| 资产报酬率 (ROA TTM) | -5.26% |
| 股东权益报酬率 (ROE TTM) | -13.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看涨 | 看涨 |
| Diagnostics & Research (全球的) | 看涨 | 看涨 | |
| 股票 | Myriad Genetics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | 1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.30 |
|
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Value |
| 内部持股比例 | 2.77% |
| 机构持股比例 | 104.21% |
| 52周波幅 | ||
| 中 | 8.50 (22.30%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Piper Sandler | 11 Nov 2025 | 8.50 (22.30%) | 购买 | 6.68 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| HAAS KEVIN RICHARD | 5.47 | - | 23,697 | 129,623 |
| MUZZEY DALE | 5.47 | - | 23,697 | 129,623 |
| VERRATTI MARK | 5.47 | - | 32,810 | 179,471 |
| WHEELER BENJAMIN RICHARD | 5.47 | - | 4,994 | 27,317 |
| 累积净数量 | 85,198 | |||
| 累积净值 ($) | 466,033 | |||
| 累积平均购买 ($) | 5.47 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| MUZZEY DALE | 职员 | 02 Feb 2026 | 获得 (+) | 23,697 | 5.47 | 129,623 |
| HAAS KEVIN RICHARD | 职员 | 02 Feb 2026 | 获得 (+) | 23,697 | 5.47 | 129,623 |
| WHEELER BENJAMIN RICHARD | 职员 | 02 Feb 2026 | 获得 (+) | 4,994 | 5.47 | 27,317 |
| VERRATTI MARK | 职员 | 02 Feb 2026 | 获得 (+) | 32,810 | 5.47 | 179,471 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合